141 filings
Page 3 of 8
8-K
03kubjqa ky
26 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
9bzk0jwntef1mo12 km
31 Jul 18
Entry into a Material Definitive Agreement
4:52pm
8-K/A
ujl7ti
2 Jul 18
Index to Financial Statements
4:05pm
8-K
l1tmmv8kurtu32
16 May 18
Regulation FD Disclosure
3:12pm
8-K
ka07c
15 May 18
Departure of Directors or Certain Officers
12:00am
8-K
5h5suvj7p5z5
14 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
xgxhix1vwx6opw7ut
30 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
ciciil6zqgnurxhrfb
29 Dec 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
0qbkfr rffe4
26 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
omv brh857egzs01rmc
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
jm0h9 1l55t
21 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K/A
j9on 4gcb
31 Mar 17
Financial Statements and Exhibits
12:00am
8-K
qugulq1
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
38s5lwzr9vqax0mmohp
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
diwoee
3 Nov 16
Regulation FD Disclosure
12:00am
8-K
6by6a ppf8rh5qs459
14 Sep 16
Regulation FD Disclosure
12:00am
8-K
suz4qi9
26 Aug 16
Financial Statements and Exhibits
12:00am
8-K
6j4j53 8ma
5 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
zigvgv2 8szwnju
22 Jan 16
OncBioMune Receives Notice of Allowance for Patent Covering New Targeted Cancer Treatments
12:00am
8-K
78s1av41ug
5 Jan 16
Unregistered Sales of Equity Securities
12:00am